A detailed history of Ade, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Ade, LLC holds 259 shares of LLY stock, worth $229,357. This represents 0.16% of its overall portfolio holdings.

Number of Shares
259
Previous 259 -0.0%
Holding current value
$229,357
Previous $201,000 16.42%
% of portfolio
0.16%
Previous 0.14%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 17, 2024

BUY
$592.2 - $792.28 $153,379 - $205,200
259 New
259 $201,000
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $56,212 - $69,760
-250 Closed
0 $0
Q2 2021

Jul 27, 2021

BUY
$180.55 - $233.54 $45,137 - $58,385
250 New
250 $57,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $841B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Ade, LLC Portfolio

Follow Ade, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ade, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ade, LLC with notifications on news.